Thrombolysis with alteplase 3–4.5 hours after acute ischaemic stroke: the first multicentre, phase III trial in China

BACKGROUND AND PURPOSE: Data on the efficacy and safety of alteplase for acute ischaemic stroke (AIS) administered 3–4.5 hours after the onset of stroke symptoms in Chinese patients is limited. We sought to determine whether AIS patients would benefit from thrombolysis with alteplase between 3 and 4...

Popoln opis

Shranjeno v:
Bibliografske podrobnosti
izdano v:Stroke Vasc Neurol
Main Authors: Zheng, Huaguang, Yang, Yi, Chen, Huisheng, Li, Chuanling, Chen, Yangkun, Shi, Fu-Dong, Yang, Li, Cui, Xiaoping, Lu, Zuneng, Liang, Yanling, Cui, Songbiao, Xu, Anding, Wu, Yiqing, Sun, Yaqing, Wang, Yongjun
Format: Artigo
Jezik:Inglês
Izdano: BMJ Publishing Group 2020
Teme:
Original Research
Online dostop:https://ncbi.nlm.nih.gov/pmc/articles/PMC7548519/
https://ncbi.nlm.nih.gov/pubmed/32467323
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1136/svn-2020-000337
Oznake: Označite
Brez oznak, prvi označite!

Podobne knjige/članki